UK-US pharma deal

Market Access

Operational review meeting minutes released by the DHSC reveal industry and government are planning to move to a 7-year agreement.

News

Bristol Myers Squibb has reported phase 3 results with a new drug for idiopathic pulmonary fibrosis that could open the door to regulatory filings.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.